
Amgen, Teva Sued Over Allegedly Anticompetitive Practices Relating to Sensipar Pricing
February 22, 2019 Amgen Inc., Teva Pharmaceuticals USA, Inc. and three Teva subsidiaries have been named in a proposed class action in which they’re accused of entering into an unlawful, anticompetitive agreement that led consumers to pay inflated prices for Sensipar.